SF3B1 and myelodysplastic syndrome: Catalán et al. found a 13% mutation rate among Uruguayan patients with MDS to be associated with older age (median age 76 years), elevated ferritin levels, and lower bone marrow blast counts compared to those without SF3B1 mutations [31].